Ingevity Corp

Listed Company
NGVTCIK 0001653477NYSELarge AcceleratedChemicals & Allied ProductsDelawareFY ends Dec 31
Period
FY 2025
Revenue
$1.17B
Net Income
$-167.10M
Total Assets
$1.65B
Equity
$29.70M
Shares Out
35.29M
Op. Cash Flow
$331.20M

Business

Ingevity Corp provides products and technologies that purify, protect, and enhance the world by developing, manufacturing, and marketing specialty chemicals and materials. It offers activated carbon for automotive vapor control and purification; road technologies including asphalt emulsifiers, warm‑mix Evotherm, pavement preservation and markings; industrial specialties such as tall oil‑derived adhesives, agrochemical dispersants, lubricant additives and rubber resins; and caprolactone‑based polymers for coatings, adhesives, elastomers, bioplastics and medical devices. The company operates three reportable segments — Performance Materials, Performance Chemicals (road technologies and industrial specialties), and Advanced Polymer Technologies. It serves global markets across the Americas, Europe and Asia through its direct sales forces and a network of third‑party distributors to customers in automotive, construction, agriculture, industrial and medical end markets.

Summary from filing dated 2025-02-19

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts
ConceptTrend
FY 2025
2025-12-31
FY 2024
2024-12-31
FY 2023
2023-12-31
FY 2022
2022-12-31
FY 2021
2021-12-31
Net sales1,1681,2001,2161,6681,392
Cost of sales7067357711,098879
Gross profit462465445570513
Selling, general, and administrative expenses171158162199179
Research and technical expenses2825253026
Restructuring and other (income) charges, net13185314
Goodwill impairment charge18430700
Long lived asset impairment charge10900
Acquisition-related costs0300,00045600,000
Other (income) expense, net258−16−2
Interest expense78989362
Interest income−5−8−6−8−4
Income (loss) from continuing operations before income taxes−142−141130270163
Provision (benefit) for income taxes on continuing operations8−19245845
Net income (loss) from continuing operations−150−121106
Income (loss) from discontinued operations, net of income taxes−17−309−111
Net income (loss)−167−430−5212118
Basic earnings (loss) per share from continuing operations (usd per share)−4.15−3.342.9
Basic earnings (loss) per share from continuing operations (usd per share)−0.46−8.51−3.05
Basic earnings (loss) per share (usd per share)−4.61−11.85−0.155.542.97
Diluted earnings (loss) per share from continuing operations (usd per share)−4.15−3.342.88
Diluted earnings (loss) per share from discontinued operations (usd per share)−0.46−8.51−3.03
Diluted earnings (loss) per share (usd per share)−4.61−11.85−0.155.52.95

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro